Percival M - Search Results

1

Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial.

Kopmar NE, Quach K, Gooley TA, Martino CH, Cherian S, Percival MM, Halpern AB, Ghiuzeli CM, Oehler VG, Abkowitz JL, Walter RB, Cassaday RD. Kopmar NE, et al. Among authors: percival mm. JAMA Oncol. 2024 May 9:e240967. doi: 10.1001/jamaoncol.2024.0967. Online ahead of print. JAMA Oncol. 2024. PMID: 38722664

2

Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms.

Kopmar NE, Othus M, Quach K, Rasmussen A, Schonhoff K, Becker PS, Walter RB, Halpern AB, Salit R, Cassaday RD, Shustov A, Stewart FM, Oehler VG, Scott BL, Sandmaier BM, Lee SJ, Estey EH, Percival MM. Kopmar NE, et al. Among authors: percival mm. Transplant Cell Ther. 2024 May 5:S2666-6367(24)00376-2. doi: 10.1016/j.jtct.2024.05.002. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38710302

3

Medication reuse programs: a narrative review of the literature.

Watts S, Coutsouvelis J, Wickens J, Poole S, Percival M, Zalcberg JR. Watts S, et al. Among authors: percival m. Int J Qual Health Care. 2024 Apr 30;36(2):mzae036. doi: 10.1093/intqhc/mzae036. Int J Qual Health Care. 2024. PMID: 38687831 Review.

4

Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203.

Percival ME, Zhang M, Othus M, McMillen K, Erba H, Garcia-Manero G, Pagel J, Sorror M. Percival ME, et al. Res Sq [Preprint]. 2024 Mar 11:rs.3.rs-4020184. doi: 10.21203/rs.3.rs-4020184/v1. Res Sq. 2024. PMID: 38559108 Free PMC article. Preprint.

5

Gestational vitamin D and offspring fracture risk: do associations persist into mid adolescence?

Percival MA, Anderson KB, Pasco JA, Hosking SM, Williams LJ, Holloway-Kew KL, Wark JD, Hyde NK. Percival MA, et al. Eur J Clin Nutr. 2024 Mar 1. doi: 10.1038/s41430-024-01421-z. Online ahead of print. Eur J Clin Nutr. 2024. PMID: 38429375

6

Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control.

Ebadi M, Morse M, Gooley T, Ermoian R, Halasz LM, Lo SS, Yang JT, Blau MH, Percival ME, Cassaday RD, Graber J, Taylor LP, Venur V, Tseng YD. Ebadi M, et al. Among authors: percival me. J Neurooncol. 2024 Jan;166(2):351-357. doi: 10.1007/s11060-023-04501-5. Epub 2024 Jan 20. J Neurooncol. 2024. PMID: 38244173

7

Time independent factors that predict relapse in adults with acute myeloid leukemia.

Lim JJ, Othus M, Shaw CM, Russell K, Halpern AB, Appelbaum JS, Hendrie P, Walter RB, Estey EH, Percival MM. Lim JJ, et al. Among authors: percival mm. Blood Cancer J. 2024 Jan 15;14(1):5. doi: 10.1038/s41408-023-00954-z. Blood Cancer J. 2024. PMID: 38221523 Free PMC article. No abstract available.

8

Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.

Altman JK, Zuckerman T, Koprivnikar J, McCloskey J, Kota V, Keng M, Frankfurt O, Abaza Y, Bixby DL, Emadi A, Burch M, Bhatnagar B, Luger SM, Percival ME, Wolach O, Craig M, Ganzel C, Roboz G, Levi I, Gourevitch A, Flaishon L, Tessler S, Blumberg C, Gengrinovitch S, Ben Yakar R, Rowe JM. Altman JK, et al. Among authors: percival me. Blood Adv. 2023 Dec 26;7(24):7494-7500. doi: 10.1182/bloodadvances.2023010943. Blood Adv. 2023. PMID: 37903324 Free PMC article. Clinical Trial.

9

Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.

Zarling LC, Stevenson PA, Soma LA, Martino CH, Percival MM, Halpern AB, Ghiuzeli CM, Becker PS, Oehler VG, Cooper JP, Orozco JJ, Hendrie PC, Walter RB, Estey EH, Cassaday RD. Zarling LC, et al. Among authors: percival mm. Eur J Haematol. 2023 Dec;111(6):863-871. doi: 10.1111/ejh.14089. Epub 2023 Sep 5. Eur J Haematol. 2023. PMID: 37670560

10

Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms.

Shih L, Othus M, Schonhoff K, Shaw C, Appelbaum J, Halpern AB, Becker PS, Walter RB, Estey E, Percival ME. Shih L, et al. Among authors: percival me. Leukemia. 2023 Sep;37(9):1912-1914. doi: 10.1038/s41375-023-01981-2. Epub 2023 Jul 31. Leukemia. 2023. PMID: 37524920 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page